Availability |
An EMA-approved treatment is available |
1.5 |
AND |
A treatment intervention is available (diet, HSCT, BMT) |
1 |
A treatment is in late development (phase 3) |
1 |
A treatment is in early development (preclinical, phase 1, or phase 2) |
0.5 |
Outcomes |
The treatment strategy changes the prognosis for all forms of the disorder |
1.5 |
OR |
The treatment strategy changes the prognosis for some forms of the disorder |
1 |
The treatment strategy does not change prognosis or improves only some symptoms of the disorder |
0.5 |
Pre-symptomatic initiation results in better outcomes |
1 |
AND |